Suchergebnisse - "Keenan, Robert T"

PubPharm (6)

1

The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout

enthalten in: Rheumatology (Oxford, England) | 2024

von Baraf, H. | Khanna, P. | Kivitz, A. | +8

2

Pegloticase causes prolonged improvement in multiple disease parameters in patients with chronic refractory gout who maintain low serum urate levels

enthalten in: Clinical and experimental rheumatology | 2022

von Keenan, R. | Yeo, A. | Lipsky, P.

3

Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response

enthalten in: Current rheumatology reports | 2022

von Botson, J. | Baraf, H. | Keenan, R. | +10

4

The effect of immunomodulators on the efficacy and tolerability of pegloticase : a systematic review

enthalten in: Seminars in arthritis and rheumatism | 2021

von Keenan, R. | Botson, J. | Masri, K. | +4

5

Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking

enthalten in: Clinical rheumatology | 2017

von Modjinou, D. | Krasnokutsky, S. | Gyftopoulos, S. | +7

6

Pegloticase failure and a possible solution : Immunosuppression to prevent intolerance and inefficacy in patients with gout

enthalten in: Seminars in arthritis and rheumatism | 2017

von Berhanu, A. | Krasnokutsky, S. | Keenan, R. | +1

1
[1]